Medicine
Octreotide 500 mcg/1 mL injection
Octreotide 500 mcg/1 mL injection is a generic prescription medicine for intravenous, subcutaneous use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
For prolonged storage, octreotide acetate single dose should be stored at…
Key facts
- Active ingredient (INN)
- Octreotide
- Brand
- Sold under the generic name
- Strength
- 500 mcg/1 mL
- Dosage form
- Injection
- Route
- Intravenous, subcutaneous
- Packs
- 10 vials of 1 mL, 10 syringes of 1 mL and 5 more
- Manufacturers
- Avet PharmaceuticalsIndiaGland PharmaIndiaGlenmark PharmaceuticalsIndiaFresenius KabiHikma PharmaceuticalsMeitheal PharmaceuticalsMylan Institutional
- Origin register
- US FDA, United States
- Storage
- For prolonged storage, octreotide acetate single dose should be stored at refrigerated temperatures 2°C to 8°C (36°F to 46°F) and protected from light. At room temperature (20°C to 30°C or 70°F to 86°F), octreotide acetate injection is stable for 14 days if protected from light. The solution can be allowed to come to room temperature prior to administration.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H01CB02 Octreotide
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 April 2005
- Identifiers
- RxCUI 312069, 312070, 1090558 +5DailyMed set ID d6a9a800-889d-417f-b533-1913197d0022, 2d78d5d1-77b2-4da1-98d4-d9c36e743ce2, 884e4287-a4d8-4a6e-8d99-dbe5e88875b9 +5NDC 63323-377, 67457-246, 68083-560 +4Application ANDA077457, ANDA079198, ANDA216839 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, glass in 1 carton / 1 mL in 1 vial, glass | 23155-689-41 | Avet PharmaceuticalsIndia | 25 May 2022 |
| 10 vial in 1 carton / 1 mL in 1 vial | 68083-560-10 | Gland PharmaIndia | 22 June 2023 |
| 10 vial in 1 carton / 1 mL in 1 vial | 68462-897-10 | Glenmark PharmaceuticalsIndia | 9 August 2023 |
| 10 vial, single-dose in 1 tray / 1 mL in 1 vial, single-dose | 63323-377-01 | Fresenius Kabi | 14 March 2006 |
| 10 vial, single-dose in 1 tray / 1 mL in 1 vial, single-dose | 63323-377-04 | Fresenius Kabi | 14 March 2006 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 0641-6176-10 | Hikma Pharmaceuticals | 4 April 2005 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 71288-568-02 | Meitheal Pharmaceuticals | 28 February 2025 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 67457-246-01 | Mylan Institutional | 1 April 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Octreotide 500 mcg/1 mL injection.
Other strengths and forms of Octreotide
Clinical summary
Octreotide is a somatostatin analog indicated to reduce blood levels of growth hormone (GH) and insulin growth factor-1 (IGF-1, somatomedin C) in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection. MedsAcross supplies Octreotide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OctreotideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Sandostatin prescribing information (Novartis Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Oczyesa: European public assessment report (EPAR) · European Medicines Agency
Need Octreotide 500 mcg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.